Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.

Gondi V, Hermann BP, Mehta MP, Tomé WA.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):348-54. doi: 10.1016/j.ijrobp.2012.11.031.

PMID:
23312272
2.

Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.

Gondi V, Hermann BP, Mehta MP, Tomé WA.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e487-93. doi: 10.1016/j.ijrobp.2011.10.021. Epub 2011 Dec 29.

3.

Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.

Tsai PF, Yang CC, Chuang CC, Huang TY, Wu YM, Pai PC, Tseng CK, Wu TH, Shen YL, Lin SY.

Radiat Oncol. 2015 Dec 10;10:253. doi: 10.1186/s13014-015-0562-x.

4.

A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction.

Farjam R, Pramanik P, Aryal MP, Srinivasan A, Chapman CH, Tsien CI, Lawrence TS, Cao Y.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):908-15. doi: 10.1016/j.ijrobp.2015.08.014. Epub 2015 Aug 8.

5.
6.

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1133-41.

PMID:
10613305
7.

Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas?

Pinkham MB, Bertrand KC, Olson S, Zarate D, Oram J, Pullar A, Foote MC.

J Clin Neurosci. 2014 Jan;21(1):86-90. doi: 10.1016/j.jocn.2013.04.005. Epub 2013 Oct 3.

PMID:
24090519
8.

A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone.

Chang EL, Wefel JS, Maor MH, Hassenbusch SJ 3rd, Mahajan A, Lang FF, Woo SY, Mathews LA, Allen PK, Shiu AS, Meyers CA.

Neurosurgery. 2007 Feb;60(2):277-83; discussion 283-4.

PMID:
17290178
9.

Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.

Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):974-9. doi: 10.1016/j.ijrobp.2009.06.025. Epub 2009 Oct 26.

PMID:
19864079
10.

Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1388-95.

PMID:
17674975
11.

Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors.

Kocher M, Treuer H, Hoevels M, Semrau R, Sturm V, Mueller RP.

Strahlenther Onkol. 2013 Feb;189(2):137-41. doi: 10.1007/s00066-012-0269-y. Epub 2012 Dec 20.

PMID:
23283589
12.

Single-dose versus fractionated stereotactic radiotherapy for brain metastases.

Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H, Lee SH.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):483-9. doi: 10.1016/j.ijrobp.2010.05.033. Epub 2010 Aug 26.

PMID:
20800386
13.

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.

Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Shah S, Shi W, Wendland M, Kachnic L, Mehta MP.

J Clin Oncol. 2014 Dec 1;32(34):3810-6. doi: 10.1200/JCO.2014.57.2909. Epub 2014 Oct 27.

14.

Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.

Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Mantovani C, Fiandra C, Anglesio S, Ragona R.

Acta Oncol. 2009;48(4):571-7. doi: 10.1080/02841860802520821.

PMID:
19031164
15.

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.

Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu AL.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):264-70. doi: 10.1016/j.ijrobp.2012.02.036. Epub 2012 Apr 18.

PMID:
22516808
16.

Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.

Levegrün S, Hof H, Essig M, Schlegel W, Debus J.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):796-808.

PMID:
15183483
17.

Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.

Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):53-8.

PMID:
10924971
18.

Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.

Nieder C, Grosu AL, Stark S, Wiedenmann N, Busch R, Kneschaurek P, Molls M.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1055-9. Epub 2005 Dec 9.

PMID:
16338100
19.

Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.

Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):75-81.

PMID:
16111574
20.

Supplemental Content

Support Center